Registration of securities issued in business combination transactions

Income Taxes - Schedule of Deferred Tax Assets (Details)

v3.20.1
Income Taxes - Schedule of Deferred Tax Assets (Details) - USD ($)
Dec. 31, 2019
Dec. 31, 2018
Income Tax Disclosure [Abstract]    
Net operating loss carry forwards $ 17,773,202 $ 15,108,073
Patent costs 423,747 382,812
Accrued Vacation 12,832 11,516
Research and development credit 5,241,066 4,314,813
Stock-based compensation 2,025,742 1,903,104
Other 10,200 8,495
Gross deferred tax assets 25,486,789 21,728,813
Valuation allowance (25,486,789) (21,728,813)
Net deferred tax assets